Undifferentiated Carcinoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
Conditions: Nasopharyngeal Nonkeratinizing Carcinoma; Recurrent Nasopharyngeal Undifferentiated Carcinoma; Stage III Nasopharyngeal Undifferentiated Carcinoma; Stage IV Nasopharyngeal Undifferentiated CarcinomaInterventions: Other: Laboratory Biomarker Analysis; Biological: NivolumabSponsor: National Cancer Institute (NCI)Not yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2015 Category: Research Source Type: clinical trials
Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
Conditions: Nasopharyngeal Nonkeratinizing Carcinoma; Recurrent Nasopharyngeal Undifferentiated Carcinoma; Stage III Nasopharyngeal Undifferentiated Carcinoma; Stage IV Nasopharyngeal Undifferentiated CarcinomaInterventions: Biological: Nivolumab; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Not yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2015 Category: Research Source Type: clinical trials
